BridgeBio Pharma
BBIO
#2311
Rank
A$10.30 B
Marketcap
$54.53
Share price
-0.94%
Change (1 day)
-4.43%
Change (1 year)

Earnings for BridgeBio Pharma (BBIO)

Earnings in 2024 (TTM): -A$0.53 Billion

According to BridgeBio Pharma 's latest financial reports the company's current earnings are A$0.21 Billion. In 2023 the company made an earning of -A$0.93 Billion a decrease over its 2022 earnings that were of -A$0.66 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BridgeBio Pharma from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.53 Billion-43.4%
2023 -A$0.93 Billion41.5%
2022 -A$0.66 Billion-25.1%
2021 -A$0.88 Billion15.11%
2020 -A$0.76 Billion67.55%
2019 -A$0.46 Billion67.65%
2018 -A$0.27 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$29.31 Million-94.91%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.2 Billion-66.95%๐Ÿ‡บ๐Ÿ‡ธ USA